Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Propionate Nasal Spray vs Montelukast in Asthma and Seasonal Allergic Rhinitis
NCT00296530Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 2005
- Primary completion
- Jul 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluticasone propionate in seasonal allergic rhinitis (SAR) and asthma (3 arms), sponsored by GSK. Primary endpoint: Morning Peak Expiratory Flow. Started Sep 2005; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
seasonal allergic rhinitis (SAR)asthma
Beyond the preview
Go deeper on NCT00296530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296530.